JP2020524172A5 - - Google Patents
Info
- Publication number
- JP2020524172A5 JP2020524172A5 JP2019571249A JP2019571249A JP2020524172A5 JP 2020524172 A5 JP2020524172 A5 JP 2020524172A5 JP 2019571249 A JP2019571249 A JP 2019571249A JP 2019571249 A JP2019571249 A JP 2019571249A JP 2020524172 A5 JP2020524172 A5 JP 2020524172A5
- Authority
- JP
- Japan
- Prior art keywords
- antibiotic
- composition
- chelating agent
- day
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023150377A JP7642033B2 (ja) | 2017-06-20 | 2023-09-15 | 肺感染症を低減させる方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017902364 | 2017-06-20 | ||
| AU2017902364A AU2017902364A0 (en) | 2017-06-20 | Method For Reducing Lung Infection | |
| AU2018900765A AU2018900765A0 (en) | 2018-03-08 | Method for Reducing Lung Infection | |
| AU2018900765 | 2018-03-08 | ||
| PCT/AU2018/050610 WO2018232453A1 (en) | 2017-06-20 | 2018-06-20 | Method for reducing lung infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023150377A Division JP7642033B2 (ja) | 2017-06-20 | 2023-09-15 | 肺感染症を低減させる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524172A JP2020524172A (ja) | 2020-08-13 |
| JP2020524172A5 true JP2020524172A5 (https=) | 2022-10-17 |
| JP7389653B2 JP7389653B2 (ja) | 2023-11-30 |
Family
ID=64735417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571249A Active JP7389653B2 (ja) | 2017-06-20 | 2018-06-20 | 肺感染症を低減させる方法 |
| JP2023150377A Active JP7642033B2 (ja) | 2017-06-20 | 2023-09-15 | 肺感染症を低減させる方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023150377A Active JP7642033B2 (ja) | 2017-06-20 | 2023-09-15 | 肺感染症を低減させる方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11382884B2 (https=) |
| EP (1) | EP3641750A4 (https=) |
| JP (2) | JP7389653B2 (https=) |
| CN (1) | CN111065386A (https=) |
| AU (3) | AU2018286650B2 (https=) |
| BR (1) | BR112019027255A2 (https=) |
| CA (1) | CA3067858A1 (https=) |
| WO (1) | WO2018232453A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210361581A1 (en) * | 2018-10-22 | 2021-11-25 | Ioi Oleo Gmbh | Additive for a powder material intended for compaction into shaped bodies |
| CN116173037A (zh) * | 2023-04-14 | 2023-05-30 | 中国人民解放军总医院 | 咖啡因在预防和/或治疗急性高原病中的应用 |
| US20250108004A1 (en) * | 2023-09-29 | 2025-04-03 | Sterilecare Inc. | Aerosol delivery of edta compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| WO2008137747A1 (en) | 2007-05-02 | 2008-11-13 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
| WO2011142677A1 (en) * | 2010-05-11 | 2011-11-17 | Breathe Easy Ltd | Methods and compositions for the treatment of lung disorders |
| AU2016228976B2 (en) * | 2015-03-11 | 2018-11-08 | University Of Cincinnati | Compositions and methods for treating bacterial infection |
-
2018
- 2018-06-20 WO PCT/AU2018/050610 patent/WO2018232453A1/en not_active Ceased
- 2018-06-20 CN CN201880040947.1A patent/CN111065386A/zh active Pending
- 2018-06-20 BR BR112019027255-0A patent/BR112019027255A2/pt not_active Application Discontinuation
- 2018-06-20 JP JP2019571249A patent/JP7389653B2/ja active Active
- 2018-06-20 CA CA3067858A patent/CA3067858A1/en active Pending
- 2018-06-20 EP EP18821470.4A patent/EP3641750A4/en active Pending
- 2018-06-20 US US16/615,072 patent/US11382884B2/en active Active
- 2018-06-20 AU AU2018286650A patent/AU2018286650B2/en active Active
-
2023
- 2023-09-15 JP JP2023150377A patent/JP7642033B2/ja active Active
- 2023-12-21 AU AU2023285900A patent/AU2023285900B2/en active Active
-
2025
- 2025-10-24 AU AU2025256218A patent/AU2025256218A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hallal et al. | Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study | |
| Bassetti et al. | Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient | |
| Michalopoulos et al. | Inhaled anti-infective agents: emphasis on colistin | |
| Vendrell et al. | Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis | |
| JP2003321389A5 (https=) | ||
| JP2024001036A5 (https=) | ||
| US9925206B2 (en) | Compositions and methods for treating bacterial infection | |
| JP2020524172A5 (https=) | ||
| JP2015232026A (ja) | 人工呼吸器関連肺炎（ｖａｐ）及び人工呼吸器関連気管（ｖａｔ）気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム | |
| CN101678004A (zh) | 治疗生物膜形成的三唑化合物 | |
| Wood et al. | Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia | |
| US8636984B2 (en) | Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | |
| CA3067858A1 (en) | Method for reducing lung infection | |
| Reyes et al. | Current perspectives: therapeutic uses of tobramycin | |
| Neu et al. | Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria | |
| JP2023071952A5 (https=) | ||
| Kuzovlev et al. | Inhaled antibiotics in treatment of nosocomial pneumonia | |
| Chacko et al. | Is it the end of the road for inhaled antibiotic therapy in ventilator-associated pneumonia? | |
| US9526697B2 (en) | Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis | |
| Carlon et al. | Serratia marcescens pneumonia | |
| JP7811652B2 (ja) | リボース及びアミノ酸を含む医薬組成物 | |
| WO2002064089A2 (en) | Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides | |
| WO2018009889A1 (en) | Antibacterial nasal compositions and related methods | |
| Holliday et al. | Effects of Nasal Alkalinization on Bacterial Colonization in Healthy Subjects | |
| Damaso et al. | Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents |